Braun-Bostich & Associates’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-728
Closed -$9K 224
2020
Q2
$9K Hold
728
0.01% 224
2020
Q1
$6K Hold
728
0.01% 236
2019
Q4
$10K Buy
+728
New +$9.29K 0.01% 239
2019
Q3
Sell
-3,856
Closed -$46K 101
2019
Q2
$46K Sell
3,856
-5,632
-59% -$67.8K 0.05% 193
2019
Q1
$112K Sell
9,488
-1,576
-14% -$17.6K 0.12% 152
2018
Q4
$112K Hold
11,064
0.12% 128
2018
Q3
$130K Buy
11,064
+816
+8% +$9.48K 0.13% 119
2018
Q2
$112K Buy
10,248
+9,568
+1,407% +$104K 0.11% 125
2018
Q1
$7K Buy
+680
New +$7.66K 0.01% 276

Other funds holding APH

Braun-Bostich & Associates's APH Position: Q3 2020 in Review

Braun-Bostich & Associates sold out of Amphenol (APH) in Q3 2020, closing a stake of 728 shares — an estimated $9K sold.

Braun-Bostich & Associates first reported a position in APH in Q1 2018 and held it in 9 quarters. The position peaked at $130K in Q3 2018. 746 funds tracked by Wall St. Rank hold APH as of Q3 2020.

  • Braun-Bostich & Associates reported no remaining Amphenol position as of Q3 2020 after selling out during the quarter.
  • Braun-Bostich & Associates sold 728 Amphenol shares in Q3 2020, an estimated $9K.
  • Braun-Bostich & Associates first reported a position in Amphenol in Q1 2018 and held it in 9 quarters.
  • Braun-Bostich & Associates's Amphenol position peaked at $130K in Q3 2018.
  • 746 funds tracked by Wall St. Rank held Amphenol as of Q3 2020.

Based on Braun-Bostich & Associates's 13F filing for Q3 2020, filed 9 Oct 2020.